Drugs / VBY-376
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00557583 | Nov 2007 → Feb 2008 | chronic hepatitis C virus infection | Virobay Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VBY-376 | “The study will evaluate the safety and pharmacokinetics of single doses of VBY-376 in healthy subjects.” NCT00557583 ↗ |